Administration of adjuvant oxaliplatin to patients with stage III colon cancer is affected by age and hospital

Authors

  • Felice N. van Erning Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, The Netherlands
  • Nienke Bernards Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, The Netherlands; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands
  • Geert-Jan Creemers Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands
  • Art Vreugdenhil Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands
  • Chantal J. P. A. Lensen Department of Internal Medicine, Hospital Bernhoven, Uden, The Netherlands
  • Valery E. P. P. Lemmens Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, The Netherlands; Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands

DOI:

https://doi.org/10.3109/0284186X.2013.878470

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2014-07-01

How to Cite

van Erning, F. N., Bernards, N., Creemers, G.-J., Vreugdenhil, A., Lensen, C. J. P. A., & Lemmens, V. E. P. P. (2014). Administration of adjuvant oxaliplatin to patients with stage III colon cancer is affected by age and hospital. Acta Oncologica, 53(7), 975–980. https://doi.org/10.3109/0284186X.2013.878470

Issue

Vol. 53 No. 7 (2014): Acta Oncologica

Section

Articles